CervoMed Inc.

CRVO · Pharmaceutical Preparations

Save to watchlist Sign in to save

Latest available SEC filing: SCHEDULE 13G ·

Latest disclosures

All company filings

Institutional holders by security

Choose a share class to see reported 13F positions and quarterly changes. Different securities have separate holder histories.

  • CRVO · 15713L109 - Common Stock, $0.001 par value
Company details and SEC sources

CIK 0001053691 · SEC filing index. Filing dates describe disclosures, not live market data.

Listed symbols
CRVO on Nasdaq
At a glance Names, identifiers, and filing context for this profile. 2 identity fields
SEC industry group
Pharmaceutical Preparations (Office of Life Sciences)
Business address
20 Park Plaza, Suite 424, Boston, MA, 02116
EDGAR profile Static EDGAR fields kept behind disclosure so the main profile stays readable. 3 profile fields available
Incorporated in
DE
Fiscal year end
31 December
Former names on EDGAR
Diffusion Pharmaceuticals Inc. (to 14 Aug 2023) RestorGenex Corp (to 14 Jan 2016) Stratus Media Group Inc (to 07 Mar 2014) FERIS INTERNATIONAL INC. (to 16 Jul 2008) TITAN MOTORCYCLE CO OF AMERICA INC (to 22 Feb 2008)
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .